Literature DB >> 19232339

Nicotine sensitization of monkey striatal dopamine release.

Edward F Domino1, Hideo Tsukada.   

Abstract

This study with monkeys was designed to answer two questions. 1) Does acute nicotine preferentially release more dopamine in the striatum than in the prefrontal cortex? 2) Do repeated doses of nicotine produce sensitization of striatal dopamine release? Microdialysis techniques were used to measure extracellular dopamine in both brain regions in two separate groups of conscious animals. The acute nicotine i.v. dose schedule was a bolus of 32 microg/kg plus an infusion of +/-0.8 microg/kg/min and a 100 microg/kg bolus plus an infusion of +/-2.53 microg/kg/min for 30 min to mimic human tobacco smoking arterial plasma nicotine concentrations. Acute nicotine given i.v. released more dopamine in the striatum than in the prefrontal cortex. In the second experiment, for convenience, daily nicotine was given i.m. and not i.v. bid in doses of 32 or 100 microg/kg for nine days. Dopamine release was measured after overnight nicotine abstinence using the i.v. dose schedule from the first experiment. Baseline dopamine release was significantly reduced (77.6% of control, P<0.05). With a lowered baseline, a greater facilitation of dopamine release was produced by nicotine compared to that obtained under control conditions when the baseline was higher. The impaired dopamine release with overnight nicotine abstinence was transiently enhanced in a dose dependent manner. These data regarding the striatum are consistent with previous findings in rodents of nicotine sensitization of dopamine release especially in nucleus accumbens following repeated administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232339     DOI: 10.1016/j.ejphar.2009.02.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

2.  A framework for designing dynamic lp-ntPET studies to maximize the sensitivity to transient neurotransmitter responses to drugs: Application to dopamine and smoking.

Authors:  Shuo Wang; Sujin Kim; Kelly P Cosgrove; Evan D Morris
Journal:  Neuroimage       Date:  2016-10-13       Impact factor: 6.556

3.  MEMRI is a biomarker defining nicotine-specific neuronal responses in subregions of the rodent brain.

Authors:  Aditya N Bade; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans.

Authors:  Bernard Le Foll; Mihail Guranda; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Victoria C Wing; Laurie Zawertailo; Usoa Busto; Peter Selby; Arthur L Brody; Tony P George; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

Review 5.  New mechanisms and perspectives in nicotine withdrawal.

Authors:  K J Jackson; P P Muldoon; M De Biasi; M I Damaj
Journal:  Neuropharmacology       Date:  2014-11-26       Impact factor: 5.250

6.  Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.

Authors:  Viswanath V Venugopalan; Kevin F Casey; Caitlin O'Hara; Jennifer O'Loughlin; Chawki Benkelfat; Lesley K Fellows; Marco Leyton
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

Review 7.  Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Authors:  Agnes J Jasinska; Todd Zorick; Arthur L Brody; Elliot A Stein
Journal:  Neuropharmacology       Date:  2013-03-06       Impact factor: 5.250

8.  The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity.

Authors:  Merideth A Addicott; Maggie M Sweitzer; F Joseph McClernon
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

Review 9.  E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology.

Authors:  Melissa Herman; Robert Tarran
Journal:  J Physiol       Date:  2020-07-06       Impact factor: 5.182

Review 10.  Early life adversity and health-risk behaviors: proposed psychological and neural mechanisms.

Authors:  Korrina A Duffy; Katie A McLaughlin; Paige A Green
Journal:  Ann N Y Acad Sci       Date:  2018-07-16       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.